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A B S T R A C T
The aim of this study is to investigate possible connection between omega-6/omega-3 fatty acid ratio and development
and progression of Age-Related Macular Degeneration (ARMD). We examined 125 patients diagnosed with ARMD and di-
vided into 5 groups of 25 patients according to CARMS (Clinical Age-Related Maculopathy Staging System). Control
group consists of 51 patients with similar ages, without ARMD. All of them underwent stereobiomicroscopy, fundus pho-
tography and fluorescein angiography. Dietary fatty acids intake was measured using food frequency questionairre (FFQ).
The FFQ was based on previously validated questionairre (DIETQ, Tinuviel Software, Warington, Ches, UK) and FFQ2
from Blue MountainEye Study. The data were analysed using food nutritient dana fromMcCance and Widdowson´s Food
Composition Tables, supplemented with a food fatty acid content database (Foodbase, London, UK). We noticed statistically
significant difference between omega-6/omega-3 ratio in neovascular ARMD (stage 5) and all other groups including con-
trol group (p=0.000020).The ratio in Stage 5 was about 11:1 like in Western diet. Stage 4-geographic atrophy (GA) has sta-
tistically significant difference in o-mega-6/omega-3 ratio compared with stage 1 (p=0.000571), stage 2 (p=0.000112) and
stage 3 (p=0.000430). The ratio in first three groups is about 7–7.5:1 (greater thenMediteran-4–5:1, but lower then Western
Diet-10–20:1). There is no statistically significant difference between first three stages (p>0.05) and stage 4 and control
group (p=0.172388). Omega-6/omega-3 ratio is connected with development of neovascular ARMD. Decreased ratio pro-
tects against neovascular ARMD. On the contrary, GA seems to be connected with prolonged sunlight exposure (the ratio is
about 6:1). It is good to know that changing nutrition habits someone can prevent development of severe neovascular form
of ARMD because intravitreal anti-VEGF therapy limitations.
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Introduction
Age-related macular degeneration (ARMD), a leading
cause of visual loss in older adults in developed countries
has limited terapeutic options1. Degenerative changes of
macular arealead to damage of central vision and cause
difficulties in reading, writing, driving, using PC and
other aspects of normal quality of today human life2. Suc-
cessful therapy is not yet available for the majority of pa-
tients, especially not for patients with severe form of
»dry« ARMD. Before the introduction of anti-VEGF (Vas-
cular Endothelial Growth Factor) medica-tions there was
no known therapy for »wet« ARMD that can actually im-
prove visual acuity.
Epidemiological studies over the last two decades
have provided insights into the risk factors associated
with ARMD including age, sex, nutritional status, smok-
ing, hypertension, sunlight exposure and genetic markers.
Therapies that focus on prevention through optimization
of modifiable risk factors such as diet and nutritional sta-
tus are key approaches to reducing the burden of disease.
Methods that help to prevent development or progres-
sion of ARMD through nutritional supplementation will
become especially important as our population increases
in longevity and the number of individuals affected with
ARMD continues to rise1,3–5.
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Given the considerable public health burden imposed
by ARMD, much effort has been directed towards discov-
ering principles of pathogenesis in order to identify risk
factors and develop preventive measures and treatments.
Together with epidemiological evidence linking cardio-
vascular risk factors with ARMD risk and basic science
work examing the role of lipid metabolism in ARMD, nu-
merous human studies have assayed a potentional rela-
tionship between dietary lipids and development of
ARMD6. Lipids and lipid metabolites have long been
known to play biological roles that go beyond energy
store and membrane structure. In ARMD dysregulation
of lipid metabolism is closely associated with disease on-
set and progression. The topics of lipoprotein modulation
and omega-3 fatty acid intake receive special attention6,7.
A large study involving researchers and patients from
eight European countries now report that regular con-
sumption of oily fish my reduce risk of developing ARMD
by 53%. The reaserchers observed a strong correlation
between fish intake and dietary intake of the two main
component of fish oil-EPA (eicosapentaenoic acid) and
DHA (docosahexaenoic acid) which is omega-3 fatty
acids8. Omega-6 and omega-3 are polyunsaturated fatty
acids and they are essential because our organism cannot
produce them and we musts get them food. For most of
the time human have been on earth we have eaten foods
containing omega-6/omega-3 ratio of about 1–2:1. How-
ever, over the last 50 years in Western diet, the ratio has
changed to 10–20:1. Our diet now includes huge amounts
of oils that are extracted from plants and used for cook-
ing or in prepared food. These oils (such as sunflower and
corn oil) are primarily omega-6. Omega-3 is found in oily
fish, in whole grains and beans. So, today we have exces-
sive amounts of omega-6 fatty acids compared with diet
on which human beings envolved and their genetic pat-
terns were established. Excessive amounts of omega-6
and a very high omega-6/omega-3 ratio, as is found in to-
day´s Western diets, promote the pathogenesis of many
chronic diseases, including cardiovascular, cancer, and
autoimmune diseases, whereas increased levels of ome-
ga-3 exert suppressive effect. In our organism omega-6
has proinflamatory and omega-3 antiinflamatory effect.
It is possible i that optimal ratio may vary with disease
under consideration9,10.
ARMD is also chronic disease and it is multigenic and
multifactorial. We try to discover values of omega-6/omega-
-3 ratio in patients diagnosed with different stages of
ARMD and influence of that ratio on development and
progression of ARMD.
Materials and Methods
The study group included 125 patients (125 eyes) di-
vided into 5 groups according to CARMS (Clinical Age-
Related Maculopathy Staging System)11. The first 3 sta-
ges represent different form of »dry« ARMD, 4th repre-
sent geographic atrophy (GA)-developed »dry« form and
5th represent neovascular form of ARMD. The control
group included 51 patients without any signs of ARMD
with similary ages as study group. All the patients were
examined in Department of Ophtalmology in Rijeka Uni-
versity Hospital.They underwent stereobiomicroscopic
examination, fundus photography and fluorescein angio-
graphy. Dietary fatty acids intake was measured by using
food frequency questionairre (FFQ). The FFQ was based
on a previously validaded questionairre (DIETQ, Tinuviel
Software, Warington, Ches, UK) and FFQ2 which had
been used in Blue Mountin Eye Study. The FFQ and
weighed records were analysed using food nutritient
dana from McCance and Widdowsons Food Composition
Tables, suplemented with a food fatty acid content data-
base (Foodbase, London, UK)12,13.
Statistical analysis of dana was performing by using
Statistica for Windows, release 8.1 (StaSoft, INC, Tulsa,
OK, USA). The dana of omega-6/omega-3 ratio were pre-
sented as the mean±standard deviation (SD) or median
and range (5th–95th percentile boundaries), depending on
the normality of distribution. We used one-way analysis
of variance (one-way ANOVA) to test the differences be-
tween the group according to omega-6/omega-3 ratio. For
post hoc analysis Tukey´s test were used. All statistical
values were considered significant at the p-level of 0.05.
Results
We noticed folowing results of omega-6/omega-3 ratio
in five different stages of ARMD and control group (Ta-
ble 1). Total number of examined patients were 176, 125
diagnosed with ARMD and 51 in control group. In the
first three groups (Stages 1, 2 and 3) we counted ratios
7.65±0.77, 7.76±0.65 and 7.67±0.70 (mean±SD) which
represent stages of mild or moderate »dry« form of ARMD.
In the stage 4-GA omega-6/omega-3 ratio was 6.44±0.68
and in the stage 5 (neovascular ARMD) ratio was 11.52±
1.83 (mean±SD). Control group has ratio of 7.04±1.05
(mean±SD). As we can see patients with neovascular
ARMD had greater values of omega-6/omega-3 ratio and
patients with GA mild lower than other groups.
Statistically significant difference was noticed between
omega-6/omega-3 ratio in neovascular ARMD group (sta-
ge 5) and ratios in all other groups including control
group (p=0.000020) (Table 2). Besides that patients in
stage 4 (GA) has statistically significant difference in
omega-6/omega-3 ratio compared with patients in stage 1
(p=0.000571), stage 2 (p=0.000112) and stage 3 (p=
0.000430). There is no statistically significant differences
between omega-6/omega-3 ratio in first 3 stages of ARMD
(p>0.05) and between stage 4 and control group (p=
0.172388).
Discussion and Conclusion
Omega-6/omega-3 ratio in mild and moderate form of
ARMD is about 7–7.5:1. This ratio is greater than in
Mediteran Diet (4–5:1) but lower than in Western Diet
(10–20:1)9,10. In group with neovascular ARMD ratio is
about 11:1 and it is like in Western Diet. Maybe it is an-
swer on question we have in our last year epidemiological
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study when we noticed greater prevalence of neovascular
ARMD in Gorski kotar where people rare consume oily
fish (omega-3) and consume great deal of plant oil (ome-
ga-6) and saturated fats14. We think that besides genet-
ics, nutritional habits,also, has important roles in con-
version from moderate form of ARMD into severe neo-
vascular form. It confirmes datas from several studies
that decreased omega-3/omega-6 ratio protects against
neovascular ARMD and acts like natural anti-VEGF fac-
tor because decreases VEGF in blood10.
Lower omega-6/omega-3 ratio, about 6–6.5:1 was no-
ticed in stage 4 (GA). It is possible that in that variant of
severe form of ARMD, which in our last study was more
frequent in islands, greater influence in conversion from
moderate to severe form has long time of sunlight ex-
posure15,16.
No significant difference between group 1 and 3 and
control group was noticed and we think that is possible
that optimal ratio may vary with disease under consider-
ation but we have to know that we cannot tell for sure in
what way and why patients with moderate form develop
severe form.
However, we can conclude that omega-6/omega-3 ra-
tio has important role in development of neovascular
form of ARMD. It is good to know in prevention of dis-
ease because intravitreal therapy with anti-VEGF medi-
cations has limitations.
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TABLE 1
OMEGA-6/OMEGA-3 FATTY ACIDS RATIO ACCORDING TO STAGES OF ARMD (MEAN SD)
Level of – Factor N –Mean±SD –Std.Err –95,00% +95,00%
Total 176 7.87±1.86 0.14 7.60 8.15
group Stage 1 25 7.65±0.77 0.15 7.34 7.97
group Stage 2 25 7.77±0.65 0.13 7.50 8.04
group Stage 3 25 7.67±0.71 0.14 7.38 7.96
group Stage 4 25 6.44±0.68 0.14 6.16 6.73
group Stage 5 25 11.52±1.83 0.37 10.76 12.27
group Control 51 7.04±1.05 0.15 6.75 7.34
ARMD – age-related macular degeneration, SD – standard deviation
TABLE 2
COMPARISON OF OMEGA-6/OMEGA-3 RATIO AMONG DIFFERENT STAGES OF ARMD AND CONTROL GROUP (p values)
Group I. II. III. IV. V. VI.
1 0.998767 1.000000 0.000571 0.000020 0.153041
2 0.998767 0.999508 0.000112 0.000020 0.047719
3 1.000000 0.999508 0.000430 0.000020 0.127637
4 0.000571 0.000112 0.000430 0.000020 0.172388
5 0.000020 0.000020 0.000020 0.000020 0.000020
6 0.153041 0.047719 0.127637 0.172388 0.000020
ARMD – age-related macular degeneration
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ULOGA OMJERA UNOSA OMEGA-6 I OMEGA-3 MASNIH KISELINA U ORGANIZAM
U RAZVOJU I PROGRESIJI SENILNE MAKULARNE DEGENERACIJE
S A @ E T A K
Cilj ove studije bio je ispitati mogu}u povezanost omjera unosa omega-6 i omega-3 masnih kiselina u organizam sa
razvojem i progresijom senilne makularne degeneracije (SMD). U tu svrhu pregledali smo 125 pacijenata s dijagnozom
SMD te ih podijelili u 5 skupina po 25 pacijenata prema stupnju te`ine bolesti. Kontrolnu skupinu ~inio je 51 pacijent
sli~ne dobi bez SMD. Svima je u~injena stereobiomikroskopija, fundus fotografija i fluoresceinska angiografija. Unos
masnih kiselina u organizam ispitan je pomo}u upitnika prehrambenih navika. Statisti~ki zna~ajna razlika zabilje`ena
je kod neovaskularnog oblika SMD u odnosu na sve ostale skupine uklju~uju}i i kontrolnu grupu (p=0,00002). Grupa 4
– geografska atrofija (GA) se statisti~ki zna~ajno razlikuje od prve 3 skupine koje predstavljaju bla`i oblik SMD (p<0,05).
Omjer unosa kod neovaskularnog oblika je oko 11:1 i odgovara zapadnja~kom tipu prehrane dok je ni`i kod ostalih
skupina (oko 7–7.5:1), a najni`i u skupini 4 (oko 6:1). Primje}ujemo izrazitu povezanost pove}anog omjera unosa ome-
ga-6/omega-3 sa razvojem neovaskularnog oblika SMD, dok smanjeni omjer djeluje protektivno. To saznanje mo`e biti
korisno u prevenciji ovog te{kog oblika SMD, jer intravitrealna terapija ima svoja ograni~enja.
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